Enovis Corporation announced that the U.S. Food and Drug Administration (FDA) has approved the STAR Patient Specific Instrumentation (STAR PSI System) for use with the Company's STAR(R) total ankle replacement system.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.17 USD | +1.26% | -0.12% | +0.27% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.27% | 3.08B | |
+12.49% | 128B | |
-8.97% | 10.66B | |
-2.20% | 8.55B | |
+15.12% | 7.1B | |
+26.97% | 5.06B | |
+7.09% | 3.4B | |
-10.28% | 2.11B | |
-8.61% | 2.03B | |
-27.27% | 1.69B |
- Stock Market
- Equities
- ENOV Stock
- News Enovis Corporation
- Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR Ankle